GW640385
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GW640385, covering 2017-05-30 to 2017-05-30. Get the full timeline:
Most recent: Clinical Trial Update: GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults [Phase 2]